Nuclease Probe Technologies will save lives, speed recovery, and reduce hospital costs with its patented diagnostic test (NucAP™) for deadly bloodstream infections. NucAP™ is a culture free, 3-hour, low cost test for bacteria directly from the bloodstream of patients suffering from life-threatening infections.
Location: United States, Alaska
Employees: 11-50